Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells

Cancer Research

Volumn 67, Issue 1, 2007, Pages 85-92

  Butcher, Neville J ^a   Tetlow, Natasha L ^a   Cheung, Catherine ^a   Broadhurst, Gysell M ^a   Minchin, Rodney F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ARYLAMINE ACETYLTRANSFERASE; CYCLOHEXIMIDE; FLUTAMIDE; LUCIFERASE; MESSENGER RNA; METRIBOLONE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ARYLAMINE N-ACETYLTRANSFERASE; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME INDUCTION; HELA CELLS; HUMANS; ISOENZYMES; MALE; METRIBOLONE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 33846403754     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2635     Document Type: Article

References (42)

1. Chan JM, Jou RM, Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol 2004;172:S13-6.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
3. Bosetti C, Micelotta S, Dal Maso L, et al. Food groups and risk of prostate cancer in Italy. Int J Cancer 2004; 110:424-8.
4. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 2001;74:549-54.
5. Cross AJ, Peters U, Kirsh VA, et al. A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 2005;65:11779-84.
6. Ross RK, Pike MC, Coetzee GA, et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 1998;58:4497-504.
7. Coughlin SS, Hall IJ. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 2002;12: 182-96.
8. Shirai T, Sano M, Tamano S, et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997;57:195-8.
9. Ito N, Shirai T, Tagawa Y, Nakamura A, Fukushima S. Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2′-dimethyl-4-amino-biphenyl. Cancer Res 1988;48:4629-32.
10. Wang CY, Debiec-Rychter M, Schut HA, et al. N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. Carcinogenesis 1999;20:1591-5.
11. Al-Buheissi SZ, Cole KJ, Hewer A, et al. The expression of xenobiotic-metabolizing enzymes in human prostate and in prostate epithelial cells (PECs) derived from primary cultures. Prostate 2006;66:876-85.
12. Hein DW, Doll MA, Nerland DE, Fretland AJ. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol Carcinog 2006; 45:230-8.
13. Di Paolo OA, Teitel CH, Nowell S, Coles BF, Kadlubar FF. Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways. Int J Cancer 2005;117:8-13.
14. Lawson T, Kolar C. Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens. Cancer Lett 2002;175:141-6.
15. Butcher NJ, Boukouvala S, Sim E, Minchin HF. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2002;2:30-42.
16. Rovito PM, Jr., Morse PD, Spinek K, et al. Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer. Prostate Cancer Prostatic Dis 2005;8:69-74.
17. Hein DW, Leff MA, Ishibe N, et al. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ Mol Mutagen 2002;40:161-7.
18. Fukutome K, Watanabe M, Shiraishi T, et al. N-Acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development. Cancer Lett 1999; 136:83-7.
19. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995;55:5226-9.
20. Dupret JM, Rodrigues-Lima F. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases. Curr Med Chem 2005;12:311-8.
21. Butcher NJ, Ilett KF, Minchin RF. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 2000;57:468-73.
22. Smolen TN, Brewer JA, Weber WW. Testosterone modulation of N-acetylation in mouse kidney. J Pharmacol Exp Ther 1993;264:854-8.
23. Estrada L, Kanelakis KC, Levy GN, Weber WW. Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1. Drug Metab Dispos 2000;28:139-46.
24. Estrada-Rodgers L, Levy GN, Weber WW. Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter. Gene Expr 1998;7: 13-24.
25. Husain A, Barker DF, States JC, Doll MA, Hein DW. Identification of the major promoter and non-coding exons of the human arylamine N- acetyltransferase 1 gene (NAT1). Pharmacogenetics 2004;14:397-406.
26. Butcher NJ, Arulpragasam A, Goh HL, Davey T, Minchin RF. Genomic organization of human arylamine N-acetyltransferase type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activities. Biochem J 2005;387: 119-27.
27. Boukouvala S, Price N, Plant KE, Sim E. Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice. Biochem J 2003;375: 593-602.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
29. Stanley LA, Coroneos E, Cuff R, Hickman D, Ward A, Sim E. Immunoctiemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem 1996;44:1059-67.
30. Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000;141:4698-710.
31. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A 1989;86:327-31.
32. Blankvoort BM, de Groene EM, van Meeteren-Kreikamp AP, Witkamp RF, Rodenburg RJ, Aarts JM. Development of an androgen reporter gene assay (ARLUX) utilizing a human cell line with an endogenously regulated androgen receptor. Anal Biochem 2001;298: 93-102.
33. Lu S, Tsai SY, Tsai MJ. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Endocrinology 1999;140:5054-9.
34. Butcher NJ, Arulpragasam A, Minchin RF. Proteasomal degradation of N-acetyltransferase 1 is prevented by acetylation of the active site cysteine-a mechanism for the slow acetylator phenotype and substrate-dependent down-regulation. J Biol Chem 2004;279:22131-7.
35. Ing NH. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol Reprod 2005;72:1290-6.
36. Paolo Rosini LB, Elisabetta B, Chiara C, et al. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: Role of FGF2 in growth, survival, and androgen receptor down-modulation. Prostate 2002;53:310-21.
37. 4 integrin-mediated invasive phenotype. Endocrinology 2000;141:3172-82.
38. Taneja SS, Ha S, Swenson NK, et al. Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem 2005;280:40916-24.
39. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84.
40. Zhang C, Li HR, Fan JB, et al. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 2006;7:202.
41. Minchin RF, Kadlubar FF, Ilett KF. Role of acetylation in colorectal cancer. Mutat Res 1993;290:35-42.
42. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002;506-507:65-77.